Effective Trading and Stock Investing
Trusted Market Insights for Active Investors – Backed by 30 Years of Expertise at Wicked Stocks.
Trusted Market Insights for Active Investors – Backed by 30 Years of Expertise at Wicked Stocks.
pharmaceutical
pharmaceutical
Celldex
Technical Analysis on Celldex Celldex Therapeutics (CLDX) posts meaningful buy signal into later Q3 In this Wicked Stocks video-analysis, we inform you of this week’s buy-signal in Celldex Therapeutics (CLDX). As customary, we provide you buy-zone support and targeted resistance, that if reached over the next several months would yield gains approaching 100%. We have […]
Crispr Therapeutics
Crispr Therapeutics (CRSP) elicits recent buy signal, gains of 25%+ anticipated in the coming weeks In this Wicked Stocks video-analysis, Cary shows Crispr Therapeutics (CRSP) eliciting a buy-signal last week, anticipating gains of 25% or more over the coming weeks. The analysis includes specific price support for resting bids, and resistance for profit-taking offers. You […]
Precipio
Precipio Inc (PRPO) tests significant ceiling this week; settlement above signals gains of 80-100% within weeks In this Wicked Stocks video-analysis, Cary walks you through the Precipio Inc (PRPO) charts, showing how this microcap tested a significant ceiling of resistance this week. Closing above this area in the weeks ahead should yield gains approaching 100% […]
Premium Preview: Precipio
Precipio stock technical analysis Precipio Inc (PRPO) tests significant ceiling this week; settlement above signals gains of 80-100% within weeks Precipio stock (PRPO) rally with more potential gains to come In this Wicked Stocks video-analysis, Cary walks you through the Precipio Inc (PRPO) charts, showing how this microcap tested a significant ceiling of resistance this […]
Teva Pharmaceuticals
Teva Pharmaceuticals finds longer-term overhead ceiling, and a significant buy signal upon settlement above In this Wicked Signal video-analysis on Teva Pharmaceuticals (TEVA), Cary walks you through the charts to illustrate an overhead price-ceiling able to contain buying into later year, and if settled above, a buy signal that could yield gains of 30% over […]
Dynavax
Dynavax Technologies (DVAX) rallied 50% on Monday, Feb 1, approaching long-term resistance. Get the full technical analysis here.
Basic Posts February 2021 Analysis Premium Posts
- By Madeline Wicked Stocks
- ..
- 4 years ago
- ..
- 0 Comments
